華寶國際(00336.HK)成員公司再斥3.2億人幣認購金融產品
華寶國際(00336.HK)公佈,集團成員公司於9月26日向平安銀行認購投資本金爲2億元人民幣(下同)的保本結構性存款,大概年回報率2.9415%至3.1629%,預計將於到期日(今年12月26日)收取的利息爲150.52萬元。目前向平安銀行認購仍未到期的該等平安金融產品合計投資總額爲8.5億元。
另外,同日集團成員公司認購興業銀行投資本金爲1.2億元的保本結構性存款,大概年回報率1.5%至3.24%,預期將於到期日(今年12月28日)收到的利息爲91.65萬元。目前已認購興業銀行提供合計投資總額爲5.4億元的若幹金融產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.